Eli Lilly and Company – Page 3

6 Reasons That It’s Hard to Get Your Wegovy and Other Weight-Loss Prescriptions

An array of obstacles make it difficult for patients to obtain Wegovy or Zepbound. Finding Wegovy is “like winning the lottery,” one nurse practitioner said.

By Reed Abelson and Rebecca Robbins

Drugs (Pharmaceuticals) Eli Lilly and Company Health Insurance and Managed Care Novo Nordisk A/S Obesity Ozempic (Drug) Prices (Fares, Fees and Rates) Semaglutide (Drug) Tirzepatide

How Much Do Ozempic and Wegovy Cost? Not What You Think.

Drug companies are making billions from a new class of in-demand weight-loss treatments. But the prices are not what they seem.

By Gina Kolata

Capvision Partners China Corporations Eli Lilly and Company Foreign Investments International Relations Mintz Group LLC United States

In China, the Police Came for the Consultants. Now the C.E.O.s Are Alarmed.

Foreign businesses, a top Chinese official said in March, “are not foreigners, but family.” Then came a crackdown on firms with foreign ties.

By Daisuke Wakabayashi Ana Swanson and Lauren Hirsch

Brain Drugs (Pharmaceuticals) Eli Lilly and Company Research

Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease

Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.

By Gina Kolata

mosaec